{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:31:59Z","timestamp":1785508319980,"version":"3.56.0"},"reference-count":54,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"unspecified","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["2008501"],"award-info":[{"award-number":["2008501"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["2033264"],"award-info":[{"award-number":["2033264"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000683","name":"Royal Society of Tropical Medicine and Hygiene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000683","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian National Health Medical Research Council","award":["1182950"],"award-info":[{"award-number":["1182950"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2026,6,13]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Adherence to radical cure for\n                      <jats:italic>Plasmodium vivax<\/jats:italic>\n                      remains a major challenge for malaria control programmes. Novel regimens, such as 7-day high-dose primaquine regimen and single-dose tafenoquine, may improve treatment adherence and antirelapse effectiveness but can increase the risk of haemolysis in individuals with glucose-6-phosphate dehydrogenase deficiency. Stakeholder (ie, policymakers, providers, patients, etc) perceptions of these risks may significantly influence the acceptability and uptake of these regimens. Understanding these perceptions is essential for policymakers to design effective communication and implementation strategies of novel radical cure strategies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Guided by qualitative methodology and a risk perception lens, this study explored\n                      <jats:italic>P. vivax<\/jats:italic>\n                      malaria stakeholders\u2019 experiences and interpretations of novel radical cure regimens. Between February and September 2023, 58 semistructured interviews and 6 focus group discussions were conducted at Arba Minch General Hospital and three health centres and health posts within the Gamo Zone of the South Ethiopia Regional State: Lante, Shecha and Shele. Participants included clinical trial staff and participants, health centre personnel, health extension workers and routine care patients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 7-day-high-dose primaquine regimen and single-dose tafenoquine were viewed as promising solutions to the adherence challenges of the standard 14-day primaquine regimen; however, participants raised concerns about the effectiveness of the shortened treatment duration and the safety of the increased daily dose of primaquine. A risk perception lens revealed that concerns about effectiveness and safety were influenced by prior public health messaging emphasising completion of the full 14-day regimen alongside fears of overdosing and drug-induced haemolysis. Pill characteristics, including number, shape and colour as well as fears of overdosing and drug-induced haemolysis also contributed to apprehension about the safety of these regimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Participants\u2019 perceptions of shortened radical cure regimens were shaped by concerns about effectiveness and safety, influenced by prior treatment messaging and pill characteristics such as higher dosing and pill burden. A risk perception lens can inform implementation and communication strategies for novel regimens, where addressing user perceptions alongside practical improvements, such as reducing pill burden, is essential for optimising uptake and adherence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2025-021763","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:10:33Z","timestamp":1782738633000},"page":"e021763","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Risk perceptions of high-dose primaquine and tafenoquine among\n                    <i>Plasmodium vivax<\/i>\n                    malaria stakeholders in Ethiopia: a qualitative study"],"prefix":"10.1136","volume":"11","clinical-trial-number":[{"clinical-trial-number":"nct04411836","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-5999","authenticated-orcid":false,"given":"Muthoni","family":"Mwaura","sequence":"first","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia"},{"name":"Department of Health Ethics and Society, Care and Public Health Research Institute, Maastricht University, Maastricht, LI, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Engel","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia"},{"name":"Department of Health Ethics and Society, Care and Public Health Research Institute, Maastricht University, Maastricht, LI, Netherlands"},{"name":"Athena Institute, Vrije Universiteit Amsterdam, Amsterdam, Limburg, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhaba","family":"Kejela","sequence":"additional","affiliation":[{"name":"Department of Sociology and Social Anthropology, Arba Minch University, Arba Minch, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kansite Gellebo","family":"Korra","sequence":"additional","affiliation":[{"name":"Department of Sociology and Social Anthropology, Arba Minch University, Arba Minch, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsegabehan","family":"Wodaj","sequence":"additional","affiliation":[{"name":"Department of English Language and Literature, Arba Minch University, Arba Minch, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamiru","family":"Shibiru Degaga","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia"},{"name":"College of Medicine & Health Sciences, Arba Minch University, Arba Minch, Ethiopia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5734-0845","authenticated-orcid":false,"given":"Benedikt","family":"Ley","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia"},{"name":"Division of Education, Menzies School of Health Research, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2000-2874","authenticated-orcid":false,"given":"Ric","family":"Price","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia"},{"name":"Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK"},{"name":"Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Krumeich","sequence":"additional","affiliation":[{"name":"Department of Health Ethics and Society, Care and Public Health Research Institute, Maastricht University, Maastricht, LI, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-7497","authenticated-orcid":false,"given":"Kamala","family":"Thriemer","sequence":"additional","affiliation":[{"name":"Global and Tropical Health Division, Menzies School of Health Research, Darwin, Northern Territory, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"2026062906100879000_11.6.e021763.1","unstructured":"World Health Organization . World malaria report 2024: addressing inequity in global malaria response. Geneva, 2024."},{"key":"2026062906100879000_11.6.e021763.2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009781","article-title":"Plasmodium vivax epidemiology in Ethiopia 2000-2020: A systematic review and meta-analysis","volume":"15","author":"Ketema","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2026062906100879000_11.6.e021763.3","doi-asserted-by":"publisher","DOI":"10.1086\/512241"},{"key":"2026062906100879000_11.6.e021763.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pt.2020.03.009"},{"key":"2026062906100879000_11.6.e021763.5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1080\/14787210.2016.1220304","article-title":"Management of relapsing Plasmodium vivax malaria","volume":"14","author":"Chu","year":"2016","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2026062906100879000_11.6.e021763.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008838","article-title":"The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia","volume":"14","author":"Thriemer","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2026062906100879000_11.6.e021763.7","unstructured":"WHO . WHO guidelines for malaria 2024. Geneva: World Health Organization, 2024."},{"key":"2026062906100879000_11.6.e021763.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003799","article-title":"The global burden of Plasmodium vivax malaria is obscure and insidious","volume":"18","author":"Battle","year":"2021","journal-title":"PLoS Med"},{"key":"2026062906100879000_11.6.e021763.9","unstructured":"WHO . WHO guidelines for malaria 2023. Geneva, 2023. Available: http:\/\/apps.who.int\/bookorders"},{"key":"2026062906100879000_11.6.e021763.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-023-04725-w","article-title":"Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis","volume":"22","author":"Mehdipour","year":"2023","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.11","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1473-3099(23)00430-9","article-title":"Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis","volume":"24","author":"Commons","year":"2024","journal-title":"The Lancet Infect Dis"},{"key":"2026062906100879000_11.6.e021763.12","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50474"},{"key":"2026062906100879000_11.6.e021763.13","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(23)00431-0","article-title":"Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis","volume":"24","author":"Rajasekhar","year":"2024","journal-title":"The Lancet Infect Dis"},{"key":"2026062906100879000_11.6.e021763.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-019-2981-x","article-title":"Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia","volume":"18","author":"Lo","year":"2019","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.15","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2538-4","article-title":"Glucose-6-phosphate dehydrogenase (G6PD) deficiency in Ethiopia: absence of common African and Mediterranean allelic variants in a nationwide study","volume":"17","author":"Assefa","year":"2018","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.16","doi-asserted-by":"crossref","unstructured":"Engel N , Ochodo EA , Karanja PW , et al . Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views. Cochrane Database Syst Rev 2022. doi:10.1002\/14651858.CD014877.pub2","DOI":"10.1002\/14651858.CD014877.pub2"},{"key":"2026062906100879000_11.6.e021763.17","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1111\/risa.13615","article-title":"The Evolving Field of Risk Communication","volume":"40","author":"Balog-Way","year":"2020","journal-title":"Risk Anal"},{"key":"2026062906100879000_11.6.e021763.18","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1080\/13669877.2024.2447258","article-title":"The relationship between risk perception and risk management: a systematic literature review","volume":"27","author":"Bin-Husayn","year":"2024","journal-title":"J Risk Res"},{"key":"2026062906100879000_11.6.e021763.19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/jrfm14060272","article-title":"The Relationship between Risk Perception and Risk Definition and Risk-Addressing Behaviour during the Early COVID-19 Stages","volume":"14","author":"Grima","year":"2021","journal-title":"JRFM"},{"key":"2026062906100879000_11.6.e021763.20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0963662520963365","article-title":"Knowledge, (mis-)conceptions, risk perception, and behavior change during pandemics: A scoping review of 149 studies","volume":"29","author":"Majid","year":"2020","journal-title":"Public Underst Sci"},{"key":"2026062906100879000_11.6.e021763.21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/risa.13599","article-title":"Reflections on 40 Years of Research","volume":"40","author":"Siegrist","year":"2020","journal-title":"Risk Anal"},{"key":"2026062906100879000_11.6.e021763.22","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2147\/RMHP.S462411","article-title":"Perceptions of Risk, Benefit and Trust - A Comparative Assessment Between Healthcare Workers and the General Public Towards 3 Medical Technologies","volume":"17","author":"Ramot","year":"2024","journal-title":"Risk Manag Healthc Policy"},{"key":"2026062906100879000_11.6.e021763.23","unstructured":"Savin-Baden M , Major Howell C . Qualitative research: the essential guide to theory and practice. London: Routledge, 2013."},{"key":"2026062906100879000_11.6.e021763.24","doi-asserted-by":"crossref","unstructured":"Degaga TS , Pasaribu AP , Tripura R , et al . Effectiveness and Safety of High Dose Primaquine and Tafenoquine in Plasmodium vivax Patients (EFFORT) - A Multi-Centre, Open Label, Superiority Randomised Controlled Trial. The Lancet Infect Dis 2026. doi:10.2139\/ssrn.5409116","DOI":"10.2139\/ssrn.5409116"},{"key":"2026062906100879000_11.6.e021763.25","first-page":"1","article-title":"Community health extension program of Ethiopia, 2003-2018: successes and challenges toward universal coverage for primary healthcare services","volume":"15","author":"Assefa","year":"2019","journal-title":"Global Health"},{"key":"2026062906100879000_11.6.e021763.26","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-023-10253-9","article-title":"Challenges and experience of the Ethiopian rural health extension program: implications for reform and revitalization","volume":"23","author":"Zerfu","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2026062906100879000_11.6.e021763.27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001160","article-title":"Community health extension workers\u2019 training and supervision in Ethiopia: Exploring impact and implementation challenges for non-communicable disease service delivery","volume":"2","author":"Tesema","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"2026062906100879000_11.6.e021763.28","doi-asserted-by":"crossref","DOI":"10.1186\/s41256-019-0127-x","article-title":"Exploring health workforce regulation practices and gaps in Ethiopia: a national cross-sectional study","volume":"4","author":"Dejene","year":"2019","journal-title":"Glob Health Res Policy"},{"key":"2026062906100879000_11.6.e021763.29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1108\/TR-06-2020-0257","article-title":"Antecedents and outcomes of health risk perceptions in tourism, following the COVID-19 pandemic","volume":"76","author":"Godovykh","year":"2021","journal-title":"TR"},{"key":"2026062906100879000_11.6.e021763.30","doi-asserted-by":"crossref","DOI":"10.1017\/cts.2025.56","article-title":"How do study participants want to be informed about study results: Findings from a malaria trial in Cambodia, Ethiopia, Pakistan, and Indonesia","volume":"9","author":"Bamboro","year":"2025","journal-title":"J Clin Transl Sci"},{"key":"2026062906100879000_11.6.e021763.31","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-024-11971-4","article-title":"Addressing concerns of access and distribution of health workforce: a discrete choice experiment to develop rural attraction and retention strategies in southwestern Ethiopia","volume":"24","author":"Hilo","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"2026062906100879000_11.6.e021763.32","unstructured":"WHO . Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003."},{"key":"2026062906100879000_11.6.e021763.33","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12936-023-04578-3","article-title":"Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study","volume":"22","author":"Rahmalia","year":"2023","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003615","article-title":"A mixed methods study investigating factors affecting adherence to Plasmodium vivax malaria primaquine radical cure regimens among migrants along the Myanmar-Thailand border","volume":"5","author":"Ansari","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"2026062906100879000_11.6.e021763.35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/s12936-023-04743-8","article-title":"Interventions for promoting patients\u2019 adherence to 14-day primaquine treatment in a highly malaria-endemic township in Myanmar: a qualitative study among key stakeholders","volume":"22","author":"Win","year":"2023","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.36","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-018-2380-8","article-title":"Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group","volume":"17","author":"Thriemer","year":"2018","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.37","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-025-05525-0","article-title":"Perceptions of shorter radical cure Plasmodium vivax treatment regimens and their implementation: a qualitative study among stakeholders in Cambodia","volume":"24","author":"Cassidy-Seyoum","year":"2025","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.38","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-024-05209-1","article-title":"Assessing tafenoquine implementation in Brazil: a qualitative evaluation of perceptions of healthcare providers and Plasmodium vivax patients (QualiTRuST Study)","volume":"23","author":"Santos","year":"2024","journal-title":"Malar J"},{"key":"2026062906100879000_11.6.e021763.39","unstructured":"WHO . Advances in malaria chemotherapy: report of a who scientific group. Geneva, 1984."},{"key":"2026062906100879000_11.6.e021763.40","unstructured":"WHO . Chemotherapy of malaria: technical report series no.226. Geneva, 1961."},{"key":"2026062906100879000_11.6.e021763.41","unstructured":"WHO . Chemotherapy of malaria: revised second edition. Geneva, 1986."},{"key":"2026062906100879000_11.6.e021763.42","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-1"},{"key":"2026062906100879000_11.6.e021763.43","doi-asserted-by":"crossref","unstructured":"kasperson jx , kasperson re , pidgeon n , et al . The social amplification of risk: assessing fifteen years of research and theory. In: the social amplification of risk. cambridge university press, 2003.","DOI":"10.1017\/CBO9780511550461.002"},{"key":"2026062906100879000_11.6.e021763.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-18832-z","article-title":"Factors influencing risk perception during Public Health Emergencies of International Concern (PHEIC): a scoping review","volume":"24","author":"Yin","year":"2024","journal-title":"BMC Public Health"},{"key":"2026062906100879000_11.6.e021763.45","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1080\/13669877.2020.1758193","article-title":"Risk perceptions of COVID-19 around the world","volume":"23","author":"Dryhurst","year":"2020","journal-title":"J Risk Res"},{"key":"2026062906100879000_11.6.e021763.46","doi-asserted-by":"publisher","DOI":"10.1111\/0272-4332.203034"},{"key":"2026062906100879000_11.6.e021763.47","doi-asserted-by":"publisher","DOI":"10.1111\/risa.13325"},{"key":"2026062906100879000_11.6.e021763.48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1057\/palgrave.rm.8240177","article-title":"Translating Risk Management Knowledge: The Lessons to be Learned from Research on the Perception and Communication of Risk","volume":"6","author":"Maule","year":"2004","journal-title":"Risk Manag"},{"key":"2026062906100879000_11.6.e021763.49","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/00140139.2017.1349935","article-title":"Influence of drug colour on perceived drug effects and efficacy","volume":"61","author":"Tao","year":"2018","journal-title":"Ergonomics"},{"key":"2026062906100879000_11.6.e021763.50","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.sapharm.2006.10.004","article-title":"Perceptions of drug color among drug sellers and consumers in rural southwestern Nigeria","volume":"3","author":"Brieger","year":"2007","journal-title":"Res Social Adm Pharm"},{"key":"2026062906100879000_11.6.e021763.51","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-1"},{"key":"2026062906100879000_11.6.e021763.52","doi-asserted-by":"publisher","DOI":"10.1007\/BF00143739"},{"key":"2026062906100879000_11.6.e021763.53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-8721.2006.00461.x"},{"key":"2026062906100879000_11.6.e021763.54","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.socscimed.2006.10.034","article-title":"Managing risk: risk perception, trust and control in a Primary Care Partnership","volume":"64","author":"Walker","year":"2007","journal-title":"Soc Sci Med"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2025-021763","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:11:00Z","timestamp":1782738660000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2025-021763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,29]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjgh-2025-021763"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2025-021763","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}